BNP (B-type Natriuretic Peptide) Dosage Guide
Complete guide to BNP (B-type Natriuretic Peptide) dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
25 mcg – 100 mcg
Frequency
Once per day
Route
subcutaneous
Cycle Length
1–4 weeks
Reconstitution
Vial Size
1 mg
BAC Water
1.0 ml
Concentration
1,000 mcg/ml
Detailed Dosage Information
Nesiritide (recombinant BNP)
2mcg/kg IV bolus followed by 0.01mcg/kg/min continuous infusion for acute decompensated heart failure.
Administration Method
Intravenous administration only. Used in acute care settings for heart failure. BNP levels also used diagnostically.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 1 mg/ml
Volume to inject: 0.063 ml
Syringe units: 6.3 units — fits 0.3 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with BNP (B-type Natriuretic Peptide) defaults. Adjust values as needed.
Side Effects to Monitor
Hypotension (common and dose-limiting), headache, nausea, and potential renal function worsening in some patients.
Safety Considerations & Risks
Controversial efficacy data. Concerns about renal effects and mortality in some studies led to reduced use. Requires careful hemodynamic monitoring.